www.medscape.com
Stem Cell-Derived Islets Still Producing Insulin at 1 Year
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.